Vringo (VRNG) Launches New Version of Facetones Customized for Latest Nokia Mobile Devices

Amorcyte, a NeoStem (NBS) Company, Enrolls First Patient in Phase 2 Trial for AMR-001

Corporate Profile interviews Butch Flatt, CEO of ARCIS (ARCS)

Oramed Pharmaceuticals (ORMP) Granted Australian Patent

Vringo (VRNG) Announces New Version of Facetones App That Includes Enhanced Text Messaging

Medgenics (MDGN) Receives Allowance for Key European Patent

Pluristem (PSTI) Awarded a $2.4 Million Grant From Israeli Government

Rexahn (RNN) Secures Approval to Conduct a First-in-Human Trial of RX-3117

Vringo (VRNG) Launches Facetones™ App on the iPhone®

Implant Sciences’ (IMSC) Quantum Sniffer QS-H150 Deployed at Major International Bank in Middle East